Paradigm Medical Industries, Inc. (PDMI)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2011 | 441 Thousand USD | -13.36% |
| 2010 | 509 Thousand USD | 0.99% |
| 2009 | 504 Thousand USD | -23.52% |
| 2008 | 659 Thousand USD | -22.2% |
| 2007 | 847 Thousand USD | -10.37% |
| 2006 | 945 Thousand USD | 10.79% |
| 2005 | 853 Thousand USD | 18.47% |
| 2004 | 720 Thousand USD | -28.22% |
| 2003 | 1 Million USD | -62.14% |
| 2002 | 2.64 Million USD | -48.37% |
| 2001 | 5.13 Million USD | 15.38% |
| 2000 | 4.44 Million USD | 5.88% |
| 1999 | 4.2 Million USD | 500.0% |
| 1998 | 700 Thousand USD | -12.5% |
| 1997 | 800 Thousand USD | 100.0% |
| 1996 | 400 Thousand USD | 0.0% |
| 1995 | 400 Thousand USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2011 FY | 441 Thousand USD | -13.36% |
| 2010 FY | 509 Thousand USD | 0.99% |
| 2009 FY | 504 Thousand USD | -23.52% |
| 2009 Q1 | 632 Thousand USD | -4.1% |
| 2008 Q2 | 911 Thousand USD | -1.41% |
| 2008 Q3 | 853 Thousand USD | -6.37% |
| 2008 Q4 | 659 Thousand USD | -22.74% |
| 2008 Q1 | 924 Thousand USD | 9.09% |
| 2008 FY | 659 Thousand USD | -22.2% |
| 2007 Q3 | 1.09 Million USD | 9.28% |
| 2007 Q1 | 841 Thousand USD | -11.01% |
| 2007 Q2 | 1 Million USD | 19.14% |
| 2007 Q4 | 847 Thousand USD | -22.65% |
| 2007 FY | 847 Thousand USD | -10.37% |
| 2006 FY | 945 Thousand USD | 10.79% |
| 2006 Q1 | 820 Thousand USD | -3.87% |
| 2006 Q2 | 786 Thousand USD | -4.15% |
| 2006 Q4 | 945 Thousand USD | 8.25% |
| 2006 Q3 | 873 Thousand USD | 11.07% |
| 2005 Q3 | 1.3 Million USD | 75.47% |
| 2005 FY | 853 Thousand USD | 18.47% |
| 2005 Q1 | 745 Thousand USD | 3.47% |
| 2005 Q2 | 746 Thousand USD | 0.13% |
| 2005 Q4 | 853 Thousand USD | -34.84% |
| 2004 Q2 | 801 Thousand USD | -7.72% |
| 2004 FY | 720 Thousand USD | -28.22% |
| 2004 Q4 | 720 Thousand USD | -6.49% |
| 2004 Q1 | 868 Thousand USD | -13.46% |
| 2004 Q3 | 770 Thousand USD | -3.87% |
| 2003 Q4 | 1 Million USD | -46.22% |
| 2003 FY | 1 Million USD | -62.14% |
| 2003 Q3 | 1.86 Million USD | -5.23% |
| 2003 Q1 | 2.4 Million USD | -9.21% |
| 2003 Q2 | 1.96 Million USD | -18.17% |
| 2002 FY | 2.64 Million USD | -48.37% |
| 2002 Q4 | 2.64 Million USD | -33.53% |
| 2002 Q3 | 3.98 Million USD | -18.76% |
| 2002 Q2 | 4.9 Million USD | -5.03% |
| 2002 Q1 | 5.16 Million USD | 0.66% |
| 2001 Q1 | 4.49 Million USD | 1.15% |
| 2001 FY | 5.13 Million USD | 15.38% |
| 2001 Q4 | 5.13 Million USD | -8.67% |
| 2001 Q3 | 5.61 Million USD | 21.58% |
| 2001 Q2 | 4.62 Million USD | 2.73% |
| 2000 Q2 | 5.82 Million USD | 44.75% |
| 2000 Q3 | 6.15 Million USD | 5.74% |
| 2000 Q4 | 4.44 Million USD | -27.76% |
| 2000 Q1 | 4.02 Million USD | -4.24% |
| 2000 FY | 4.44 Million USD | 5.88% |
| 1999 Q3 | 1.6 Million USD | 45.45% |
| 1999 Q4 | 4.2 Million USD | 162.5% |
| 1999 FY | 4.2 Million USD | 500.0% |
| 1999 Q1 | 800 Thousand USD | 14.29% |
| 1999 Q2 | 1.1 Million USD | 37.5% |
| 1998 Q2 | 900 Thousand USD | 12.5% |
| 1998 Q1 | 800 Thousand USD | 0.0% |
| 1998 FY | 700 Thousand USD | -12.5% |
| 1998 Q4 | 700 Thousand USD | -30.0% |
| 1998 Q3 | 1 Million USD | 11.11% |
| 1997 Q4 | 800 Thousand USD | -20.0% |
| 1997 Q2 | 600 Thousand USD | 0.0% |
| 1997 FY | 800 Thousand USD | 100.0% |
| 1997 Q3 | 1 Million USD | 66.67% |
| 1997 Q1 | 600 Thousand USD | 50.0% |
| 1996 Q3 | 400 Thousand USD | 0.0% |
| 1996 Q2 | 400 Thousand USD | 0.0% |
| 1996 FY | 400 Thousand USD | 0.0% |
| 1996 Q4 | 400 Thousand USD | 0.0% |
| 1995 FY | 400 Thousand USD | 0.0% |
| 1995 Q3 | 400 Thousand USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| American Medical Technologies Inc. | 133.82 Thousand USD | -229.525% |
| Ansell Limited | 457.04 Million USD | 99.904% |
| Ansell Limited | 457.9 Million USD | 99.904% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 43.33 Million USD | 98.982% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 27.89 Thousand USD | -1481.212% |
| Psykey, Inc. | 49.94 Thousand USD | -783.06% |
| ConvaTec Group Plc | 395.54 Million USD | 99.889% |
| ConvaTec Group Plc | 396.1 Million USD | 99.889% |
| Encision Inc. | 1.4 Million USD | 68.553% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | -9294.00 USD | 4844.997% |
| LifePoint, Inc. | 2.3 Million USD | 80.904% |
| Medite Cancer Diagnostics, Inc. | 2.4 Million USD | 81.648% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 91.88 Thousand USD | -379.963% |
| Reflect Scientific, Inc. | 972.29 Thousand USD | 54.643% |
| SmileDirectClub, Inc. | 49.87 Million USD | 99.116% |
| Sector 10, Inc. | - USD | -Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 351.74 Million USD | 99.875% |
| SheerVision, Inc. | 339.66 Thousand USD | -29.835% |
| United Health Products, Inc. | 33.59 Thousand USD | -1212.578% |
| Vasamed, Inc. | 449.02 Thousand USD | 1.788% |
| Wearable Health Solutions, Inc. | 8555.00 USD | -5054.88% |
| Yubo International Biotech Limited | 322.17 Thousand USD | -36.883% |